Biology of inflammation in Crohn's disease: Mechanisms of action of anti-TNF-α therapy

Canadian Journal of Gastroenterology

Volumn 14, Issue SUPPL. C, 2000, Pages

  Targan, Stephan R ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Crohn's disease; Inflammation; Mechanisms of action; Tumour necrosis factor alpha

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; CROHN DISEASE; DOWN REGULATION; DRUG EFFECT; HUMAN; IMMUNOLOGY; INFLAMMATION; INTESTINE MUCOSA; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

ANIMALS; CROHN DISEASE; DOWN-REGULATION; HUMANS; INFLAMMATION; INTESTINAL MUCOSA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034263825     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Stenson WF. Inflammatory bowel disease. In: Yamada T, ed. Textbook of Gastroenterology, 2nd edn. Philadelphia: JB Lippincott Company, 1995:1748-806.
2. Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989;7:145-73.
3. Powrie F, Coffman RL. Cytokine regulation of T-cell function: potential for therapeutic intervention. Immunol Today 1993;14:270-4.
4. Flesch IE, Hess JH, Huang S, et al. Early interleukin 12 production by macrophages in response to mycobacterial infection depends on interferon gamma and tumor necrosis factor alpha. J Exp Med 1995;181:1615-21.
5. Hernandez-Pando R, Rook GA. The role of TNF-alpha in T-cell-mediated inflammation depends on the Th1/Th2 cytokine balance. Immunology 1994;82:591-5.
6. MacDonald TT, Hutchings P, Choy MY, Murch S, Cooke A. Tumor necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine. Clin Exp Immunol 1990;81:301-5.
7. Murch SH, Braegger CP, Walker-Smith JA, MacDonald TT. Location of tumor necrosis factor alpha by immunohistochemistry in chronic inflammatory bowel disease. Gut 1993;34:1705-9.
8. Isaacs KL, Sartor RB, Haskill S. Cytokine messenger RNA profiles in inflammatory bowel disease mucosa detected by polymerase chain reaction amplification. Gastroenterology 1992;103:1587-95.
9. Stevens C, Walz G, Singaram C, et al. Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 expression in inflammatory bowel disease. Dig Dis Sci 1992;37:818-26.
10. van Dulleman HM, van Deventer SJ, Hommes DW, et al. Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology 1995;109:129-35.
11. Targan SR, Hanauer SB, van Deventer SJ, et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor-α for Crohn's disease. Crohn's Disease cA2 Study Group. N Engl J Med 1997;337:1029-35.
12. Radema SA, van Dullemen HM, Mevissen M, Tytgat GNJ, van Deventer SJH. Anti-tumor necrosis factor therapy decreases production of the chemokines rantes, MCP, and MIP-2 in patients with Crohn's disease. Gastroenterology 1995;108:A898. (Abst)
13. Plevy SE, Landers CJ, Prehn J, et al. A role for TNF-alpha and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease. J Immunol 1997;159:6276-82.
14. Vassalli P. The pathophysiology of tumor necrosis factors. Annu Rev Immunol 1992;10:411-52.
15. Feldmann M, Elliott MJ, Woody JN, Maini RN. Anti-tumor necrosis factor-alpha therapy of rheumatoid arthritis. Adv Immunol 1997;64:283-350.
16. Murch SH, Braegger CP, Walker-Smith JA, MacDonald TT. Location of tumor necrosis factor-alpha by immunohistochemistry in chronic inflammatory bowel disease. Gut 1993;34:1705-9.
17. MacDonald TT, Hutchings P, Choy MY, Murch S, Cooke A. Tumor necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine. Clin Exp Immunol 1990;81:301-5.
18. Reimund JM, Wittersheim C, Dumont S, et al. Mucosal inflammatory cytokine production by intestinal biopsies in patients with ulcerative colitis and Crohn's disease. J Clin Immunol 1996;16:144-50.
19. Reimund JM, Wittersheim C, Dumont S, et al. Increased production of tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 by morphologically normal intestinal biopsies from patients with Crohn's disease. Gut 1996;39:684-9.
20. Reinecker HC, Steffen M, Witthoeft T, et al. Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin Exp Immunol 1993;94:174-81.
21. Breese EJ, Michie CA, Nicholls SW, et al. Tumor necrosis factor-alpha producing cells in the intestinal mucosa of children with inflammatory bowel disease. Gastroenterology 1994;106:1455-66.
22. Braegger CP, Nicholls S, Murch SH, Stephens S, MacDonald TT. Tumor necrosis factor alpha in stool as a marker of intestinal inflammation. Lancet 1992;339:89-91.
23. Mizoguchi E, Mizoguchi A, Bhan AK. Role of cytokines in the early stages of chronic colitis in TCR alpha-mutant mice. Lab Invest 1997;76:385-97.
24. low CD4+ cells are important for the balance between protective and pathogenic cell mediated immunity. J Exp Med 1994;179:589-600.
25. high CD4+ T cells. Immunity 1994;179:589-600.
26. Mizoguchi A, Mizoguchi E, Bhan AK. The critical role of interleukin 4 but not interferon gamma in the pathogenesis of colitis in T-cell receptor alpha mutant mice. Gastroenterology 1999;116:320-6.
27. Strober W, Kelsall B, Fuss I, et al. Reciprocal IFN-gamma and TGF-beta responses regulate the occurrence of mucosal inflammation. Immunol Today 1997;18:61-4.